Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NDatalyzeNDATF EV-to-EBIT is -12.69 as of Aug. 02, 2026. Among 471 Healthcare Providers & Services companies, NDatalyze ranks worse than 212314.01% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
NDatalyze's Enterprise Value for the quarter that ended in Feb. 2026 was $0.58 Mil.
NDatalyze's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NDatalyze EV-to-EBIT Related Terms
NDatalyze EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for NDatalyze's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NDatalyze's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NDatalyze EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where NDatalyze's EV-to-EBIT falls into.
NDatalyze's current Enterprise Value is $1.83 Mil.
NDatalyze's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NDatalyze (NDATF) has a EV-to-EBIT of -12.69 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on NDatalyze and its competitors. According to the industry distribution chart, NDatalyze ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is NDatalyze's EV-to-EBIT too high?
NDatalyze's current EV-to-EBIT is -12.69. Based on the distribution chart, NDatalyze ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does NDatalyze's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NDatalyze ranks #999999 out of 471 companies for EV-to-EBIT. This places NDatalyze in the lower half of its industry. The industry median EV-to-EBIT is 15.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on NDatalyze and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current EV-to-EBIT is -12.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
NDatalyze (NDATF) has a current EV-to-EBIT of -12.69. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current EV-to-EBIT is -12.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For NDatalyze (NDATF), the current EV-to-EBIT is -12.69 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NDATF has been successfully added to your 
